Sudeep Pharma: Mr. Sendhil Pani ceases to be Senior Management Personnel

Kmp ResignedManagement Changes View source PDF Explain this filing

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹1179.00

prior close

₹1199.00

announcement price

After-mkt

timing

Nifty Microcap 250market+1.3%-3.1% vs market

Specialty Chemicals peers, median of 100sector+1.6%-3.4% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 3.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.5

15m

-0.6

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+1.3-3.1+1.6-3.4

Next day

+0.0+1.1-1.1+1.9-1.9

-5.9-1.7-4.2-0.3-5.6

-10.5-1.5-9.1-0.4-10.1

-12.8-0.6-12.1-0.0-12.7

-14.1-0.4-13.7+0.2-14.3

-14.2-1.4-12.8+0.0-14.2

15d

-4.7-6.0+1.4-5.6+0.9

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Sendhil Pani, Managing Director of wholly-owned subsidiary Sudeep Pharma USA Inc., has ceased to be Senior Management Personnel (SMP) of Sudeep Pharma Limited, effective 2nd October 2026. The change is due to completion of contractual arrangements between the company and Mr. Pani. He will no longer be associated with the company as SMP under SEBI Listing Regulations.

Likely market impact

Routine governance update. SMP departure due to contract completion, no misconduct indicated. Limited direct impact on operations or share price.